Lonza acknowledged on Monday (12/12/2016) that it was holding talks with private equity company KKR concerning the potential take-over of Capsugel, a designer and producer of caspule and other drug delivery systems.
13 Dec 2016
A major acquisition in sight?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A major acquisition in sight?
Lonza Group AG (0QNO:LON) | 0 0 0.0% | Mkt Cap: 22,735m
- Published:
13 Dec 2016 -
Author:
Fabrice Farigoule -
Pages:
2
Lonza acknowledged on Monday (12/12/2016) that it was holding talks with private equity company KKR concerning the potential take-over of Capsugel, a designer and producer of caspule and other drug delivery systems.